InsiderTrades.com logo

KRRO Insider Trading

Insider Ownership Percentage: 5.40%
Insider Buying (Last 12 Months): $999,992.00
Insider Selling (Last 12 Months): $855,504.16

Korro Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Korro Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Korro Bio Share Price & Price History

Current Price: $37.00
Price Change: ▲ Price Increase of +0.02 (0.05%)
As of 01/17/2025 05:00 PM ET

This chart shows the closing price history over time for KRRO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Korro Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/11/2024Vineet AgarwalCFOSell800$70.00$56,000.00View SEC Filing Icon  
10/17/2024Vineet AgarwalCFOSell10,216$78.26$799,504.16View SEC Filing Icon  
4/22/2024Venture Opportunity Fund AtlasMajor ShareholderBuy17,857$56.00$999,992.00195,074View SEC Filing Icon  
11/22/2023David L LucchinoDirectorSell1,156$37.69$43,569.6422,150View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Korro Bio (NASDAQ:KRRO)

13.18% of Korro Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KRRO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Korro Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/26/2024JPMorgan Chase & Co.12,391$0.41M0.0%+374.9%0.132%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC137,497$4.60M0.0%-1.5%1.467%Search for SEC Filing on Google Icon
11/15/2024Vestcor Inc3,000$100K0.0%N/A0.032%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP13,052$0.44M0.0%N/A0.139%Search for SEC Filing on Google Icon
11/15/2024State Street Corp118,765$3.97M0.0%+18.9%1.268%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.444,850$14.87M0.0%-2.5%4.748%Search for SEC Filing on Google Icon
11/14/2024Eventide Asset Management LLC391,166$13.07M0.2%-26.1%4.207%Search for SEC Filing on Google Icon
11/14/2024Verition Fund Management LLC93,289$3.12M0.0%-23.8%1.003%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC3,639$0.12M0.0%+129.0%0.039%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets4,909$0.16M0.0%+1,018.2%0.053%Search for SEC Filing on Google Icon
11/13/2024FMR LLC579,563$19.37M0.0%-9.3%6.232%Search for SEC Filing on Google Icon
11/13/2024Brown Brothers Harriman & Co.2,854$95K0.0%+251.0%0.031%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC1,777$59K0.0%+172.1%0.019%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.456,085$15.45M0.0%+71.6%4.918%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC116,858$3.96M0.0%N/A1.260%Search for SEC Filing on Google Icon
8/15/2024Lynx1 Capital Management LP3,800$0.13M0.0%N/A0.041%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC84,201$2.85M0.0%+38.3%0.908%Search for SEC Filing on Google Icon
8/14/2024NEA Management Company LLC1,090,793$36.95M2.8%+1.7%11.763%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP9,103$0.31M0.0%-32.1%0.098%Search for SEC Filing on Google Icon
8/14/2024Tri Locum Partners LP71,428$2.42M0.6%N/A0.770%Search for SEC Filing on Google Icon
8/9/2024Brown Brothers Harriman & Co.813$28K0.0%N/A0.009%Search for SEC Filing on Google Icon
8/9/2024Atlas Venture Life Science Advisors LLC1,137,149$38.52M4.1%+1.6%12.263%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers8,227$0.28M0.0%N/A0.089%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp19,148$0.65M0.0%N/A0.207%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.419,226$37.73M1.0%+0.1%4.522%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.266,667$24M0.0%-1.6%3.324%Search for SEC Filing on Google Icon
2/20/2024Eventide Asset Management LLC546,325$26.19M0.4%N/A73.828%Search for SEC Filing on Google Icon
2/14/202472 Investment Holdings LLC276,831$13.27M58.9%N/A37.410%Search for SEC Filing on Google Icon
2/12/2024Monashee Investment Management LLC90,805$4.35M0.8%N/A12.271%Search for SEC Filing on Google Icon
2/9/2024Atlas Venture Life Science Advisors LLC1,119,292$53.65M6.4%N/A151.256%Search for SEC Filing on Google Icon
1/10/2024North Star Investment Management Corp.1,000$48K0.0%N/A0.135%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Korro Bio logo
Korro Bio, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases primarily in the United States. Its lead product candidate is KRRO-110 which is in preclinical trials for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, OPERA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe alcohol-associated hepatitis, and other subsets of pain. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Read More on Korro Bio

Today's Range

Now: $37.00
Low: $36.40
High: $38.35

50 Day Range

MA: $46.74
Low: $35.26
High: $73.50

52 Week Range

Now: $37.00
Low: $30.00
High: $98.00

Volume

58,033 shs

Average Volume

112,567 shs

Market Capitalization

$346.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03

Who are the company insiders with the largest holdings of Korro Bio?

Korro Bio's top insider investors include:
  1. Venture Opportunity Fund Atlas (Major Shareholder)
  2. David L Lucchino (Director)
  3. Vineet Agarwal (CFO)
Learn More about top insider investors at Korro Bio.